CD44 and breast carcinoma: Moreover, our observation that two substrates of Src signaling, i.e. cortactin and paxillin, underpin CD44-promoted adhesion and the positive correlation of CD44 to distant metastasis, is intriguing given the enrichment of Src activity detected in breast cancers with high propensity to spread to the bone [26, 27].